Empowering the CRISPR/Cas9 platform globally

ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology. Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services. Licenses are available in a wide range of fields.

Licensing

Licenses are available in a wide range of fields, including:

  • Target discovery and validation
  • High-throughput screening
  • Development and GMP production of therapeutic proteins and vaccines
  • Diagnostics
  • Animal models of disease
  • All internal R&D including sharing cell and animal models with collaborators
  • Cell lines for laboratory research and/or manufacturing
  • Animal models for laboratory research and/or manufacturing
  • Discovery and screening of novel drug targets
  • Target and pathway validation
  • Research tools, kits, and reagents
  • GMP production of healthcare products
  • CRISPR based animal therapeutics
  • Target discovery and validation
  • High-throughput screening
  • Manufacturing of therapeutic proteins and vaccines
  • All internal R&D for trait discovery and development
  • Creation and commercialization of modified strains for food and feed
  • Internal R&D of microbial, fungal, and algal strains
  • Metabolic pathway engineering
  • Strain optimization
  • Commercial manufacturing using modified strains
  • Target discovery and validation
  • High-throughput screening
  • Development and GMP production of therapeutic proteins and vaccines
  • Diagnostics
  • Animal models of disease
  • All internal R&D including sharing cell and animal models with collaborators
  • Cell lines for laboratory research and/or manufacturing
  • Animal models for laboratory research and/or manufacturing
  • Discovery and screening of novel drug targets
  • Target and pathway validation
  • Research tools, kits, and reagents
  • GMP production of healthcare products
  • CRISPR based animal therapeutics
  • Target discovery and validation
  • High-throughput screening
  • Manufacturing of therapeutic proteins and vaccines
  • All internal R&D for trait discovery and development
  • Creation and commercialization of modified strains for food and feed
  • Internal R&D of microbial, fungal, and algal strains
  • Metabolic pathway engineering
  • Strain optimization
  • Commercial manufacturing using modified strains

Some of our licensees

Internal research use:

CROs, CMOs:

Industrial bioproduction:

Tools / reagents: